Perspectives and challenges of clinical pharmacogenomics in cancer
Pharmacogenomics
.
2004 Jul;5(5):451-4.
doi: 10.1517/14622416.5.5.451.
Author
Lajos Pusztai
PMID:
15212580
DOI:
10.1517/14622416.5.5.451
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers, Tumor / genetics*
Clinical Trials as Topic / methods
Humans
Neoplasms / drug therapy
Neoplasms / genetics*
Pharmacogenetics / methods*
Substances
Biomarkers, Tumor